IBI321
IBI321 is an antibody inhibitor targeting PD-1 and TIGIT. IBI321 simultaneously blocks the PD-1-PD-L1/PD-L2 and TIGIT-CD155 inhibitory pathways, restoring T/NK cell antitumor function and promoting IL-2 production in primary human T cells. IBI321 can be used in cancer-related research.
Para uso exclusivo en investigación. No vendemos a pacientes.
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Species Reactivity
Human
Target
PD-1 & TIGIT
Conjugated
Unconjugated
Aplicación
ELISA, FACS, Functional assay
Chemical Information
-
SMILES
[IBI 321]
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)